Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Glutamine deprivation elevates EFNB3 and its potential link to macropinocytosis in glioblastoma.

Created on 31 Oct 2026

Authors

Bo Wang, Xuan Yao, Yuanping Su, Guo-QiangYuan, YaWen Pan

Published in

Biochimica et biophysica acta. Molecular basis of disease. Pages 168517. Oct 30, 2026. Epub Oct 30, 2026.

Abstract

Glioblastoma (GBM) is the most common malignant brain tumor with a poor prognosis and prominent therapeutic resistance. l-glutamine (Gln) is crucial for cancer cell survival, and the microenvironment of GBM is often accompanied by Gln deficiency. To explore the molecular mechanisms by which GBM adapts to Gln deprivation, we performed proteomic profiling of clinical GBM tissues and established a Gln-deprived cell model. Our results showed that EFNB3 was significantly upregulated under Gln deprivation. Our data suggest a potential association between EFNB3 and Rac1-GTP, which may contribute to macropinocytosis through the Cdc42/PAK1 related signaling pathway. Knockdown of EFNB3 suppressed proliferation and macropinocytosis in GBM cells. Notably, the p38 MAPK pathway may correlate with sustained Rac1-GTP abundance and macropinocytosis, whereas blocking p38 MAPK signaling appears to attenuate Rac1-GTP levels and impair macropinocytosis without affecting EFNB3 expression. Collectively, our findings reveal a potential regulatory network involving the p38 MAPK/Rac1-GTP axis linked to EFNB3, indicating that EFNB3 may act as an important modulator of metabolic adaptation in GBM.

PMID:
42962979
Bibliographic data and abstract were imported from PubMed on 31 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 11
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement